Skip to main content
Treatment of Paralysis Caused by West Nile Virus in Hamsters
Antiviral Research
  • John D. Morrey, Utah State University
  • V. Siddharthan
  • H. Wang
  • Aaron L Olsen, Utah State University
  • Ramona T. Skirpstunas, Utah State University
  • Jeffery O. Hall, Utah State University
  • H. Li
  • S. Koenig
  • S. Johnson
  • J. L. Nordstrom
  • N. Marlenee
  • R. A. Bowen
  • M. S. Diamond
Document Type
Publication Date

WNV-specific humanized monoclonal antibody (hE16) was used to treat WNV-induced poliomyelitis and fatal WNV-aerosolization when administered as a single intraperitoneal (i.p.) injection days after the virus had infected the spinal cord of rodents.

Originally published by Elsevier. Publisher's PDF and HTML fulltext available through remote link.
Citation Information
Morrey, J.D., V. Siddharthan, H. Wang, A.L. Olsen, R. Skirpstunas, J. O. Hall, H. Li, S. Koenig, S. Johnson, J. L. Nordstrom, N. Marlenee, R. A. Bowen and M.S. Diamond 2007. Treatment of Paralysis Caused by West Nile Virus in Hamsters. Antiviral Research, 74 (3): A32.